跳至主要内容
临床试验/NCT02420834
NCT02420834已完成不适用

Dry Eye Treatment With Artificial Tears

Aston University2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2015年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Symptoms

研究概览

简要总结

Dry eye is a chronic irritating eye condition that affects many people, caused by poor tear quality and insufficient quantity. Treatments are traditionally in the form of artificial tears applied to the ocular surface. However, there is little evidence in the scientific literature that demonstrates their efficacy relative compared to each other, nor how to decide which one might be most effective for an individual patient. Therefore the investigators aim to examine the efficacy of different classes of artificial tears (those designed to increase viscosity, reduce evaporation or to mimic the component balance of the natural tears). In addition, the investigators also aim to determine how the treatment preferred by an individual could potentially have been predicted from their baseline condition.

详细描述

The efficacy of different classes of artificial tears (non-pharmaceutical) will be examined in patients that report dry eyes by prescribing each category of treatment [0.40% Sodium Hyaluronate (Clinitas Soothe), 0.15% Sodium Hyaluronate (Hyabak), 0.25% Carboxymethylcellulose, electrolyte balanced (Theratears), and Phospholipid liposomal spray (Tears Again)] for a month in turn following a short wash-out period and to examine their tear film and ocular surface after each one.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subjective symptoms indicative of dry eye

排除标准

  • Sjögren's Syndrome
  • recent ocular infection
  • hay fever
  • used any eye drops or ocular medications,
  • were currently on medications known to affect the eyes
  • wore contact lenses
  • were pregnant.

研究组 & 干预措施

Tear Supplement Hypromellose 0.15%

Experimental

Preservative free Hypromellose Eye Drops BP 0.15% applied as required for 1 month

干预措施: Hypromellose 0.15% (Other)

Tear Supplement Hypromellose 0.4%

Experimental

Preservative free Hypromellose Eye Drops BP 0.4% applied as required for 1 month

干预措施: Hypromellose 0.4% (Other)

Tear Supplement Liposomal spray

Experimental

Preservative free Phospholipid liposomal spray (Tears Again) applied as required for 1 month

干预措施: Liposomal Spray (Other)

Tear Supplement Carboxymethylcellulose

Experimental

Tear Supplement 3: Preservative free 0.25% Carboxymethylcellulose, electrolyte balanced (Theratears) applied as required for 1 month

干预措施: Carboxymethylcellulose (Other)

结局指标

主要结局

Symptoms

时间窗: 4 months

Short questionnaire (Ocular Surface Disease Index)

次要结局

  • Ocular Surface Staining(4 months)
  • Phenol Red Test(4 months)
  • lid parallel conjunctival folds(4 months)
  • Non-invasive break-up time(4 months)
  • Tear meniscus height(4 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验